"My only question is, who is our bigger enemy, Jay Powell or Chairman Xi?" Trump wrote amid a series of tweets that rattled markets Friday.Politicsread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
"We don't need China and, frankly, would be far better off without them," Trump tweeted.Politicsread more
Yields slipped after Powell said that the central bank will continue to act as appropriate to sustain the economic expansion.Bondsread more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
The president tweeted Friday morning that he was ordering "our great American companies" to "immediately start looking for an alternative to China."Marketsread more
Semiconductor stocks and shares of Apple slid on Friday after President Donald Trump said U.S. companies should "immediately start looking for an alternative" to their...Technologyread more
The two American car companies are among the top exporters of U.S.-produced vehicles to China along with BMW and Daimler/Mercedes-Benz, according to industry data obtained by...Autosread more
Multinationals that rely on the supply chain from China are tumbling after President Donald Trump ordered them find alternatives to their Chinese operations.Marketsread more
Powell repeats his pledge to keep the economic expansion going while acknowledging that tariffs and other factors are causing growth to slow.The Fedread more
These are the stocks posting the largest moves in midday trading.Market Insiderread more
Check out which companies are making headlines after the bell Tuesday:
Adobe Systems - The design software maker posted second-quarter adjusted earnings per share of 37 cents on $1.07 billion in revenue. Expectations called for EPS of 30 cents on $1.03 billion in sales. Shares jumped in after-hours trading.
Endocyte - The drug developer said Merck, through a subsidiary, had decided it would no longer pursue development of vintafolide, a drug recently tested in patients with non-small cell lung cancer. Shares of Endocyte sank in after-hours trading.
La-Z Boy - The producer of reclining chairs reported fourth-quarter earnings per share of 23 cents on $353 million in revenue. Analysts had estimated EPS of 32 cents on $368 million in sales. Shares fell in after-hours trading.
—By CNBC's Kate Gibson
Questions? Comments? Email us at email@example.com